CAMBRIDGE, Mass., Nov. 22,
2022 /PRNewswire/ -- Akebia Therapeutics,
Inc. (Nasdaq: AKBA), a biopharmaceutical company with the
purpose to better the lives of people impacted by kidney disease,
today announced that the company will participate in the Piper
Sandler 34th Annual Healthcare Conference, which takes
place November 29-December 1, 2022 in
New York City, New York.
John P. Butler, Chief Executive
Officer of Akebia Therapeutics, will participate in a fireside chat
on Tuesday, November 29 at
2:30 p.m. ET.
A webcast of the fireside chat will be available through the
Investors section of Akebia's website at
https://ir.akebia.com for approximately 90 days following the
About Akebia Therapeutics
Inc. is a fully integrated biopharmaceutical company with the
purpose to better the lives of people impacted by kidney disease.
Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
View original content to download
SOURCE Akebia Therapeutics